Panagopoulos I, Mandahl N, Mitelman F, Aman P
Department of Clinical Genetics, Lund University Hospital, Sweden.
Oncogene. 1995 Sep 21;11(6):1133-7.
The FUS gene, which maps to 16p11, is fused to the CHOP gene in the t(12;16) (q13;p11) that characterizes myxoid liposarcomas (MLS) and to the ERG gene in acute myeloid leukemia (AML) with t(16;21) (p11;q22). In the present study we have mapped the breakpoints within FUS in 13 MLS with t(12;16) and in one AML with t(16;21). This region of FUS is about 3.9 kb and contains four exons. The breakpoints clustered to two zones (1 and 2). A strong association was found between the two known types of FUS/CHOP transcripts and the genomic localization of the breakpoints. In all cases expressing only type I or both type I and II FUS/CHOP transcript the genomic breakpoints mapped to zone 1. In all cases expressing only the type II transcript the breakpoints occurred in zone 2. The breakpoint in the AML case was in zone 1, suggesting that in-frame fusion transcripts are selected by similar mechanisms in both MLS and AML.
定位于16p11的FUS基因,在表征黏液样脂肪肉瘤(MLS)的t(12;16)(q13;p11)中与CHOP基因融合,在伴有t(16;21)(p11;q22)的急性髓系白血病(AML)中与ERG基因融合。在本研究中,我们确定了13例伴有t(12;16)的MLS和1例伴有t(16;21)的AML中FUS基因内的断点。FUS基因的这一区域约为3.9 kb,包含四个外显子。断点聚集在两个区域(区域1和区域2)。在两种已知类型的FUS/CHOP转录本与断点的基因组定位之间发现了强关联。在所有仅表达I型或同时表达I型和II型FUS/CHOP转录本的病例中,基因组断点定位于区域1。在所有仅表达II型转录本的病例中,断点出现在区域2。AML病例中的断点位于区域1,这表明框内融合转录本在MLS和AML中通过相似的机制被选择。